48 Hours Esophagal pH-monitoring With and Without Gaviscon
NCT02783378 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2018-05-08
Summary
At a esophagal pH-monitoring will the classic 24-hour measurement be extended to 48 hours. During the first 24 hours are the measurements without medication. After 24 hours the treatment will be started with Gaviscon and will the next 24 hours the measurements under the medication happen. Normally is the medication required after the measurements. With this study the investigators will have multiple measurement points to compare.
Conditions
- Gastroesophageal Reflux
Interventions
- DRUG
-
Gaviscon Syrup
Sponsors & Collaborators
-
Universitair Ziekenhuis Brussel
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-24
- Primary Completion
- 2017-08-01
- Completion
- 2017-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Effects of Position and a Test Meal on Esophago-gastric Junction Morphology and Function Assessed by High-resolution Impedance Manometry (HRM)
NCT02397616 ·Status: COMPLETED
-
Assessment of Gastro-esophageal Reflux Using Endo-Flip vs Bravo
NCT00481949 ·Status: COMPLETED
-
Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease
NCT03883074 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients
NCT01872897 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
NCT06084572 ·Status: RECRUITING
-
Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux
NCT01854970 ·Status: COMPLETED ·Phase: NA
-
Validation of HRM Score for the GERD Diagnosis
NCT05851482 ·Status: COMPLETED ·Phase: NA
-
Effect of Extraesophageal Reflux on Inferior Nasal Turbinates Hypertrophy
NCT04581174 ·Status: COMPLETED ·Phase: NA
-
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
NCT00414856 ·Status: COMPLETED ·Phase: PHASE1
-
Hyaluronic Acid in Patients With Gastroesophageal Reflux Disease
NCT05561179 ·Status: UNKNOWN ·Phase: NA
-
Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery
NCT01241149 ·Status: TERMINATED ·Phase: NA
-
24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis
NCT00154570 ·Status: UNKNOWN
-
High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease
NCT00461604 ·Status: COMPLETED
-
Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants
NCT03516188 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied With Their Treatment
NCT04202692 ·Status: COMPLETED ·Phase: NA
-
Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients
NCT02619747 ·Status: TERMINATED ·Phase: PHASE3
-
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
NCT01601379 ·Status: COMPLETED
-
The Difference of Reflux Pattern Between the Patients Who Have Postprandial Reflux Symptoms
NCT02154659 ·Status: COMPLETED ·Phase: NA
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Speed of Action of a Product to Control Gastric Hydration and Gastroesophageal Reflux
NCT05060744 ·Status: UNKNOWN ·Phase: NA
-
Thresholds of Straight Leg Raise Maneuver During High-Resolution-Manometry
NCT04813029 ·Status: UNKNOWN ·Phase: NA
-
Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
NCT00498082 ·Status: UNKNOWN
-
High Resolution Manometry After Partial Fundoplication for Gastro-oesophageal Reflux
NCT05132816 ·Status: RECRUITING ·Phase: NA
-
Relationship Between Gastric Accommodation, TLESRs and Reflux in HV and in GERD With or Without Overlapping Dyspepsia
NCT03788109 ·Status: COMPLETED ·Phase: NA